Article
Somatic mutational spectrum analysis in a prospective series of 104 gastrointestinal stromal tumors.
Oncology reports - 1 Mar 2017
Guenat David, Deroo Olivier, Magnin Sandrine, Chaigneau Loïc, Monnien Franck, Borg Christophe, Mougin Christiane, Emile Jean-François, Prétet Jean-Luc
Abstract excerpt
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors distinguished by driver mutations in proto-oncogenes KIT or PDGFRA in 85-90% of cases. These mutations have been linked to the response to imatinib, a multikinase inhibitor, and have independent prognostic impact. Here, we describe the prospective study of the molecular characteristics of 104 GISTs from French adult patients analyzed routinely through...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
